Why Hire CNP Holders Rigorous designation criteria ensure CNP-designated professionals will be superior contributors to an organization's bottom-line. Customers are assured of high-quality network systems being used to develop and support products and services.
The investigational CAM2038 buprenorphine subcutaneous injection products for treatment of opioid addiction are being developed as once-weekly and once-monthly formulations, each with multiple doses, to cover all phases of treatment from initiation through maintenance.
Partial Opiate Agonists. Buprenorphine is a partial opiate agonist used in medications to manage opiate withdrawal. Drugs containing buprenorphine are also used as alternatives to methadone for long-term opiate substitution. Partial opiate agonists attach to and activate opioid receptors. Two medications containing buprenorphine are available on the market â Suboxone and Subutex. These are available by prescription, eliminating the need for daily visits to a methadone clinic.